ZD6474 (Zactima) and Metronomic Chemotherapy in Advanced Breast Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

August 31, 2008

Study Completion Date

March 31, 2009

Conditions
Metastatic Breast Cancer
Interventions
DRUG

Vandetanib

Taken orally once a day in 28-day cycles (the dose will vary)

DRUG

Cyclophosphamide

Metronic Chemotherapy: Low dose pills taken every day of each 28-day cycle

DRUG

Methotrexate

Metronic Chemotherapy: low dose pills taken on days 1 and 2 of each week

Trial Locations (2)

02115

Dana-Farber Cancer Institute, Boston

02215

Massachusetts General Hospital, Boston

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

collaborator

Massachusetts General Hospital

OTHER

collaborator

Brigham and Women's Hospital

OTHER

lead

Dana-Farber Cancer Institute

OTHER